GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 634 filers reported holding GLAXOSMITHKLINE PLC in Q2 2013. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,947,000 | -87.6% | 45,143 | -87.6% | 2.39% | +134.2% |
| Q2 2016 | $15,730,000 | +2.5% | 362,947 | -4.1% | 1.02% | +10.2% |
| Q1 2016 | $15,346,000 | -2.8% | 378,469 | -3.2% | 0.93% | 0.0% |
| Q4 2015 | $15,782,000 | +0.7% | 391,129 | -4.0% | 0.93% | +19.9% |
| Q3 2015 | $15,667,000 | -9.2% | 407,454 | -1.7% | 0.77% | +3.2% |
| Q2 2015 | $17,257,000 | +97.2% | 414,339 | +8.5% | 0.75% | +112.2% |
| Q1 2015 | $8,750,000 | -59.9% | 381,930 | -25.2% | 0.35% | -60.2% |
| Q4 2014 | $21,832,000 | -13.0% | 510,815 | -6.4% | 0.89% | -4.2% |
| Q3 2014 | $25,084,000 | -16.3% | 545,668 | -2.6% | 0.92% | -8.9% |
| Q2 2014 | $29,967,000 | -5.4% | 560,331 | -5.5% | 1.02% | +28.2% |
| Q1 2014 | $31,665,000 | -8.4% | 592,639 | -8.5% | 0.79% | -7.6% |
| Q4 2013 | $34,575,000 | +27.2% | 647,590 | +19.5% | 0.86% | +18.2% |
| Q3 2013 | $27,187,000 | -37.3% | 541,893 | -37.6% | 0.72% | -44.3% |
| Q2 2013 | $43,367,000 | – | 867,863 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |